v3.22.2.2
Statements of Cash Flows - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (9,059,923) $ (11,586,292)
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities:    
Depreciation and amortization 875,604 751,498
Stock compensation expense 1,442,087 876,295
Amortization of debt costs 182,900
Interest expense on notes payable converted to common stock 3,430,858
Value of common stock issued in exchange for consulting services 148,948 1,009,601
Changes in operating assets and liabilities which used cash:    
Accounts receivable 36,575 10,000
Prepaid expenses and other assets (260,695) (72,115)
Accounts payable 77,918 (46,800)
Accrued compensation (25,852) 27,701
Deferred revenue 9,472 137,423
Other accrued liabilities 40,214 (55,755)
Net cash and cash equivalents used in operating activities (6,715,652) (5,334,686)
Cash Flows from Investing Activities    
Purchase of property and equipment (16,575) (73,427)
Investment in capitalized software (695,047) (768,899)
Net cash and cash equivalents used in investing activities (711,622) (842,326)
Cash Flows from Financing Activity    
Issuance of common stock - net of issuance costs 3,869,550 12,796,229
Net cash and cash equivalents provided by financing activity 3,869,550 12,796,229
Net (Decrease) Increase in Cash and Cash Equivalents (3,557,724) 6,619,217
Cash and Cash Equivalents - Beginning of period 10,713,091 4,093,874
Cash and Cash Equivalents - End of period 7,155,367 10,713,091
Significant Noncash Transactions:    
Acquisition of capitalized software included in accounts payable and accrued liabilities 95,387
Conversion of convertible notes payable, including accrued interest of $73,315, into 1,127,872 of common stock 2,255,745
Issuance of common stock in exchange for consulting services $ 148,948 $ 1,009,601

Source